Déconditionnement et stabilité des formes orales sèches solides : états des connaissances

Chaumeil, 2003, Le conditionnement garant de la qualité du médicament, Ann Pharm Fr, 61, 304 Le Hir, 2003, Séance thématique – Qualité, sécurité et bon usage du médicament : le rôle du conditionnement pharmaceutique (Séance organisée le 23 octobre 2003 par la 4e section de l’Académie nationale de pharmacie), Ann Pharm Fr, 61, 293 Poitou, 2003, Les missions du conditionnement en termes de sécurité et de bon usage du médicament, Ann Pharm Fr, 61, 300 Fallet, 2008, Médicaments et maisons de retraites : quand le pharmacien d’officine exerce illégalement la pharmacie industrielle, Gaz Pal Spec Droit Sante, 2, 55 Mergelin, 2009, Vers le management pharmaceutique des traitements préparés en piluliers, Sante Decision Management, 12, 239 Stolar, 1979, Expiration dates of repackaged drug products, Am J Hosp Pharm, 36, 170 Lagrange, 2010, Production robotisée des doses médicamenteuses prêtes à l’emploi. Bilan après 5 ans, Tech Hosp, 719, 13 Labrosse, 2010, Automatisation de la dispensation nominative au sein d’une pharmacie à usage intérieur. Expérience du Centre Hospitalier Le Vinatier, Ann Pharm Fr, 68, 104, 10.1016/j.pharma.2010.01.004 Andriollo, 1997, Approvisionnement pour l’aide humanitaire ou les pays en développement : la qualité du médicament essentiel multisource, STP Pharma, 7, 412 Lo-Gatto, 2003, La problématique du conditionnement au cours du développement d’une spécialité pharmaceutique, Ann Pharm Fr, 61, 295 Glass, 2009, Compliance aids and medecine stability: new evidence of quality assurance, Curr Drug Saf, 4, 74, 10.2174/157488609787354459 Medicines adherence: full guideline (January 2009) “Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence”. National Collaborating Centre for Primary Care Royal college of general practicionner 01-2009. p. 230–364. Telejko, 2007, Perindopril arginine: benefits of a new salt of the ACE inhibitor perindopril, Curr Med Res Opin, 23, 953, 10.1185/030079907X182158 Handling medicines in social care Royal Pharmaceutical society of Great Britain. Monitored dosage systems and compliance aids. 16 oct 2007. http://www.rpsgb.org.uk/pdfs/handlingmedsocialcare.pdf [consulté le 14/08/2010]. Gerber, 2008, Quantification and classification of errors associated with hand-repackaging of medications in long-term care facilities in Germany, Am J Geriatr Pharmacother, 6, 212, 10.1016/j.amjopharm.2008.10.005 Ceccarelli E, Duthoit H. Les méthodes d’étude du polymorphisme des médicaments. École Nationale Supérieure de Chimie de Rennes. http://www.membres.multimania.fr/polymorphisme/Polymorphisme.pdf [cité le 14 août 2010]. Kitchen, 2006, Pharmacist would benefit from additional stability data, Pharm J, 276, 132 Church, 2006, How stable are medicines moved from original packs into compliance aids?, Pharm J, 276, 75 Pharmaceutical society of Australia. Dose administration aids services. July 2007. http://www.psa.org.au/site.php?id=2065 [cité le 14 août 2010]. In: Qiu Y, Porter W, Liu L, Chen Y, Zhang GGZ, editors. Developing solid oral dosage forms: pharmaceutical theory and practice. I. Theories and techniques in the characterization of drug substances and excipients. Elsevier Science Ltd; 2009. [978 pages]. Pomerantz, 2004, Recycling expensive medication: why not?, Med Gen Med, 6, 4 Courtney B, Easton J, Inglesby TV, SooHoo C. Maximizing state and local medical countermeasure stockpile investments through the shelf-life extension program. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 2009;7 (1). http://www.upmc-biosecurity.org/website/resources/publications/2009/pdf/2009-03-27-max_st_local_med_cntr.pdf [cité le 14 août 2010]. Taylor, 2006, Stability profiles of drug products extended beyond labeled expiration dates, J Pharm Sci, 95, 1549, 10.1002/jps.20636 Anonyme, 2002, Drugs past their expiration date, Med Lett Drugs Ther, 44, 93 Kommanaboyina, 1999, Trends in stability testing, with emphasis on stability during distribution and storage, Drug Dev Ind Pharm, 25, 857, 10.1081/DDC-100102246 Cohen LP. Safe and effective. Many medicines prove potent for years past their expiration dates. New York Times; 2000. Frimpter, 1963, Reversible “Faconi syndrome” caused by degraded tetracycline, JAMA, 184, 111, 10.1001/jama.1963.03700150065010 Margonato, 2008, Causes of acute poisoning with medication in a southern Brazilian city, Cad Saude Publica, 24, 333, 10.1590/S0102-311X2008000200012 Bott, 2007, Storage conditions for stability testing of pharmaceuticals in hot and humid regions, Drug Dev Ind Pharm, 33, 393, 10.1080/03639040600975022 Deschamps J. Qualification des sources d’approvisionnement en médicament essentiels génériques. Application aux pays en développement. Thèse diplôme d’état de docteur en pharmacie no 47. 2005. Université Claude-Bernard Lyon I. http://www.remed.org/thesejuliendeschamps.pdf [cité le 14 août 2010]. Acquaye M. ICH Q1F guideline stability data package for registration in climatic zones III and IV comments for its application. http://www.ikev.org/haber/stabilite/kitap/34 %201.6 %20 %20Stability%20Workshop%20ICH%20Q1F%20C%20.pdf [cité le 14 août 2010]. Edwards A. International aspects of stability testing for product registration. Feb 2010 http://www.rpsgb.org/emailpdfs/allan_edwards_100222.pdf [cité le 14 août 2010]. Organisation mondiale de la santé. Tests simplifiés pour les substances pharmaceutiques. OMS; 1987. 222 pages http://apps.who.int/medicinedocs/es/d/Jh1804f/9.html [cité le 14 août 2010]. Piot S. Médicament essentiel multisource : étude de stabilité en conditions réelles Thèse diplôme d’état de docteur en pharmacie. 1997. Université de Clermont I http://www.chmp.org/html/publications.html [cité le 14 août 2010]. Mise au point sur la conservation des médicaments en cas de vague de chaleur. Afssaps 29/04/04 mise à jour en juin 2008 et le 29/06/09. http://www.afssaps.fr/var/afssaps_site/storage/original/application/1e33c6834d81ead89ed9f1fbb19aab23.pdf [cité le 14 août 2010]. Wei-Qin T. Microenvironment pH of common excipients. Excipient compatibility study: new challenges and considerations in the modern pharmaceutical R and D paradigm. American Association of Pharmaceutical Scientists Workshop: pharmaceutical stability testing to support global markets. Sept. 10–12, 2007, Bethesda, MD. Waterman, 2002, Stabilization of pharmaceuticals to oxidative degradation, Pharma Dev Tech, 7, 1, 10.1081/PDT-120002237 Waterman, 2002, Use of oxygen scavengers to stabilize solid pharmaceutical dosage forms: a case study, Pharma Dev Tech, 7, 227, 10.1081/PDT-120003490 Ching TY, Cai G, Depree C, et al. Cyclohexene derivative oxygen scavengers with reduced oxidation products for use in plastic films and beverage and food containers. Patent International Application WO 48963A2; 1999. Food and Drug Administration Compliance Policy Guide Sec. 480.200 Expiration Dating of Unit Dose Repackaged Drugs (CPG 7132b.11) 2005. http://www.fda.gov/ohrms/dockets/98fr/05d-0174-gdl0001.pdf [cité le 14 août 2010]. Pharmaceutical expiration dates. Report 1 of the Council on Scientific Affairs. American medical association: http://www.ama-assn.org/ama/no-index/about-ama/13652.shtml [cité le 14 août 2010]. Deloménie P, Fontanel-Lassale M. Conclusions du groupe de travail sur la prise en charge des médicaments dans les maisons de retraite médicalisées, sous l’égide de l’IGAS, Paris mars 2005, no 2005 022. http://www.lesrapports.ladocumentationfrancaise.fr/BRP/054000331/0000.pdf [cité le 14 août 2010]. Proposition de recommandations relatives à la préparation éventuelle des doses à administrer. Bull Ordre Pharm 2004;383:159–63. Bonne pratiques de préparation des doses à administrer (projet). http://www.synprefh.org/documents/projet_decret-arrete-pda_20090622.pdf [cité le 14 août 2010]. Lagrange F. Le reconditionnement unitaire automatisé des médicaments : expériences hospitalières. Congrès APHO avril 2006. http://www.apho.fr/posters/60/Vendredi/1100/Mr%20Lagrange.ppt [consulté le 14/08/2010]. Lashi, 2007, Interaction contenant-contenu II. Methodology: container-content interaction II. Methodology, STP Pharma Prat, 17, 143 Rapport de l’Académie de Pharmacie « Rôle des pharmaciens dans les EHPAD » http://www.acadpharm.org/dos_public/Rapport_Rle_pharmaciens_EHPAD_Vd_JPC_30122009.pdf [cité le 14 août 2010]. European commission enterprise directorate-general single market: management and legislation for consumer goods. Pharmaceuticals: regulatory framework and market authorisations. Volume 4: Good manufacturing practices. Annex 13: Manufacture of investigational medicinal products. 1983, ASHP technical assistance bulletin on repackaging oral solids and liquids in single unit and unit dose packages, Am J Hosp Pharm, 40, 451 Packaging Practice 146— Repackaging a single oral drug product into a unit-dose container. Pharmacocopeial Forum 1999;25(5):8738–46. United States Pharmacopeia 20e édition USP, General Chapter <671> Containers—Permeation, “Single-unit containers and unit-dose containers for capsules and tablets”. Leaving medication out. Medicines Policy for SNR Staff CL 108.4 Standard Operating Procedure SNR 04 (version de mars 2008). Brent Teaching Primary Care Trust. Policy for the use of medicine compliance aids. Working with our partners for a healthier Brent. 2007 revisé nov 2009. http://www.brentpct.nhs.uk/doxpixandgragix/PMMP17_PolicyForUseOfMedicineComplianceAids_1107.pdf [cité le 14 août 2010]. Pharmacy inspector newsletter 1 2006 “Compliance Aids”. http://www.dhsspsni.gov.uk/pas-pharmacy-newsletter-1.pdf [cité le 14 août 2010]. Ishak R. Which medicines are stable in compliance aids? Pinderfields Guide 2006 NHS NELM. http://www.bolton.nhs.uk/Library/services/med_manage/StabilityofDrugsinComplianceAids.pdf [cité le 14 août 2010]. Reamer, 1978, Moisture permeation of newer unit dose repackaging materials, Am J Hosp Pharm, 35, 787 Reamer, 1977, Moisture permeation of typical unit dose repackaging materials, Am J Hosp Pharm, 34, 35 Medwick, 1998, A scientific basis for beyond-use dating, Pharmacopeial Forum, 24, 5643 Expiration date labeling for extemporaneous unit-dose packages. The Consultant Pharmacist 1989;4:440. Clark TR, ASCP fact sheet beyond-use dating of repackaged oral solids. http://www.ascp.com/resources/clinical/upload/ASCP%20Fact%20Sheet%20Beyond-Use.pdf [cité le 14 août 2010]. Bulletin de la pharmacie des hôpitaux interjurassiens, Guide pratique pour l’antibiothérapie chez l’adulte. Mai 2007 http://www.pij-medic.info/site/images/stories/bulletins/allergie_penicilline.pdf [cité le 14 août 2010]. Health Guidance for Care Commission Staff. The use of monitored dosage systems and compliance aids in support services: care at home and day services for adults. The scottish comission for the regulation of care. http://www.scahonline.org/about-scah/scottish-care-publications/serve/monitored-dosage-systems-support-service [cité le 14 août 2010]. Eastham, 2006, Letters to the editor encouraging manufacturer to supply stability data, Pharma J, 276, 132 Allinson, 2001, The effects of packaging on the stability of a moisture sensitive compound, Int J Pharma, 221, 49, 10.1016/S0378-5173(01)00670-6 Zürcher J. (Schering); Topas® COC in Pharmaceutical Blister Packaging 2004 Packaging and Application Systems Development/Liquids CCD - PD Berlin. http://www.ticona.com/print/zuercher_2004.pdf [cité le 14 août 2010]. Barry J (Wyeth), Bergum J (BMS), Chen (Abbott), Chern YR (Merck), Hollander R (Pfizer), Klein D (FDA), Lockhart H (Michigan State), Malinowski D (Pfizer), McManus R (Pharma-Pack), Moreton C (Idenix), Mueller A (FDA), Nottingham L (Abbott), Okeke C (USP), O’Reilly D (GSK), Rinesmith K (Prasco), Shorts S (McNeil). Product quality research institute Container Closure Working Group Basis for using moisture vapor transmission rate per unit product in the evaluation of moisture-barrier equivalence of primary packages for solid oral dosage forms 2004. http://www.pqri.org/pdfs/whitepaper.pdf [cité le 14 août 2010]. Stahl, 1980, The problems of drug interactions with excipients, 265 Serajuddin, 1999, Selection of solid dosage form composition through drug-excipient compatibility testing, J Pharma Sci, 88, 696, 10.1021/js980434g Wyttenbach, 2005, Drug-excipient compatibility testing using a high-throughput approach and statistical design, Pharm Dev Tech, 10, 499, 10.1080/10837450500299875 In: Qiu Y, Porter W, Liu L, Chen Y, Zhang GGZ, editors. Developing solid oral dosage forms: pharmaceutical theory and practice. III. Design, development, and scale-up of formulation and process packaging selection for solid oral dosage forms. 24.4 post-approval packaging. Elsevier Science Ltd; 2009. (978 pages). Tong WQ (Novartis), Zhang GGZ (Abbott). Stability and excipient compatibility studies integrated drug product development process (3 day-course), University of Utah. July 17–19, 2006. http://www.pharmacy.utah.edu/pharmaceutics/pdf/Stability.pdf ou http://www.aapspharmaceutica.com/meetings/files/100/TonyTong.pdf [cité le 14 août 2010]. Chandler, 2005, Automated integrated forced degradation and drug-excipient compatibility studies, J Assoc Lab Automation, 10, 374, 10.1016/j.jala.2005.09.005 Megerlin, 2009, Le droit du reconditionnement des médicaments au profit des patients : entre Charybde et Scylla, Med Droit, 94, 17, 10.1016/j.meddro.2008.11.002 León Villar J, et al. Línea de Control de Calidad en el reenvasado de medicamentos. Bases metodológicas. Diseño. Utilidad. Farmacia Hosp 2001;25(1):31–7. http://www.sefh.es/fh/2001/n1/5.pdf [cité le 14 août 2010]. Jones, 1998, Emergency contraception pills: what does the law say about prescribing, dispensing repackaging and advertising?, J Am Med Womens Assoc, 53, 233 Saville, 2001, Influence of storage on in vitro release of ibuprofen from sugar coated tablets, Int J Pharma, 224, 39, 10.1016/S0378-5173(01)00734-7